Evidence map›Paper›PMID 39362075›Full record

ArticleBreast (Edinburgh, Scotland)2024

Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project.

Anna Amela Valsecchi, Filippo Giovanardi, Francesco Malandrini, Michela Meregaglia, Alberto Servetto, Chiara Bennati, Carmine Pinto, Massimo Di Maio, Oriana Ciani

Abstract read
In one paragraph

Article in Breast (Edinburgh, Scotland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna Amela ValsecchiDepartment of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, Turin, Italy.
Filippo GiovanardiMedical Oncology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.
Francesco MalandriniSDA Bocconi School of Management, Center for Research on Health and Social Care Management, Milan, Italy.
Michela MeregagliaSDA Bocconi School of Management, Center for Research on Health and Social Care Management, Milan, Italy.
Alberto ServettoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Chiara BennatiOncology Unit, Ausl Romagna Ravenna, Emilia Romagna, Italy.
Carmine PintoMedical Oncology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.
Massimo Di MaioDepartment of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, Turin, Italy. Electronic address: massimo.dimaio@unito.it.
Oriana CianiSDA Bocconi School of Management, Center for Research on Health and Social Care Management, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInclusion of patient-reported outcomes (PROs) in oncology clinical trials is strongly recommended. However, selecting the most appropriate patient-reported outcome measures (PROMs) is not easy. This study aimed to develop a breast cancer (BC) specific comprehensive archive of PROMs.

methodsAs part of the PRO4All project, we identified available PROMs in oncology by searching facit.org, eortc.org, eprovide.mapi-trust.org, PubMed, ema.europa.eu (European Public Assessment Reports) and published reviews. For this analysis, only BC tools were extracted. We described information about PROM name, type of questionnaire, questionnaire variant(s), recall period, number of items, and presence of minimum clinically important difference (MCID) reference in literature. Then, we assigned each item to a specific domain according to a predefined taxonomy of 38 items for outcome classification.

resultsWe identified and analyzed 383 PROMs. Of these, 29 were BC specific, but 2 were excluded because the questionnaires description was not available. 6 (22.2 %) were variants of another questionnaire. All questionnaires were self-reported. In 6 cases (22.2 %) the recall period to consider was the "last week". The mean number of items per questionnaire was 25.81 (range 6-71). 602 items were assigned to an outcome domain: emotional functioning/wellbeing in 26.6 % of cases, physical functioning in 14.1 %, delivery of care in 10.8 %, and general outcomes in 10.5 %. MCID reference was found only in 4 (14.8 %) cases.

conclusionsThe newly developed archive represents a useful tool to optimize the use of PROMs in the evaluation of treatments in BC patients, promoting a patient-centered approach both in clinical research and practice.

Indexed as

Breast NeoplasmsPatient Reported Outcome MeasuresBiomedical ResearchFemaleHumansMedical OncologyMinimal Clinically Important DifferenceQuality of LifeSelf ReportSurveys and QuestionnairesArchiveBreast cancerHealth-related quality of lifeOutcome domainsPatient-reported outcome measurePRO4All

Identifiers

PMID39362075
PMCPMC11651043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.